II International Symposium on Innovations in the Treatment of Coronary Artery Disease and Structural Heart Disease

The II International Symposium on Innovations in the Treatment of Coronary Artery Disease and Structural Heart Disease will take place on July 31st, 2019 at the Syrian-Lebanese Hospital in São Paulo.

Se acerca el IV Simposio de Cardiopatía Isquémica del ICBA

This event seeks to provide a better understanding of indications and clinical and interventional strategies for complex heart conditions, such as left main coronary artery obstructions, patients with acute coronary syndromes, patients at high risk for bleeding and an indication for coronary intervention, as well as percutaneous approaches to aortic stenosis (TAVR), mitral regurgitation, left atrial appendage closure, foramen ovale closure, etc.

Topics will be addressed dynamically and interactively, with clinical case presentations, conferences, and discussions, so as to provide information and improve the integration of new technologies into clinical practice.

Furthermore, this event will feature first-class international faculties.

Special Benefits

50% Off in Registration Fees for SOLACI Members!

SOLACI members registering for this event enjoy a 50% discount in the registration fee. Select “SOLACI member” in the registry system for this event and follow the instructions.

Those attending the SOLACI-SBHCI 2019 Congress will have a 50% discount on registrations to the II International Symposium of Innovations in the Treatment of Coronary and Structural Diseases

More information and registration HERE (this website is in portuguese language)

If you have questions or queries, write to secretaria.iep@hsl.org.br

This symposium is destined to: healthcare professionals, cardiologists and interventional cardiologists, cardiovascular surgeons, students, residents, nurses, and multidisciplinary teams seeking to stay updated on the latest transcatheter cardiology strategies.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

Fellow’s Corner 2026 – Submit Your Clinical Case

Share your experience. Learn from experts. Grow as an interventional cardiologist. The Latin American Society of Interventional Cardiology (SOLACI) is relaunching this year the Fellow’s...

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

The webinar “Cardiovascular Risk Factors in Women,” held on January 27, 2026, via the Zoom platform, is now available for viewing on SOLACI’s YouTube...

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial training and professional development of non-physician healthcare...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...